The Pharmacovigilance Risk
Assessment Committee (PRAC)
has started a review of nasal
and mouth sprays containing the
antibiotic fusafungine, used to treat
infections of the upper airways.
The review will encompass
the benefits and risks of these
medicines and issue an opinion
on their marketing authorisations
across the European Union, the
European Medicines Agency said.
For highlights from the PRAC 07-
10 Sep meeting and more on the
fusafungine review,The above article was sent to subscribers in Pharmacy Daily's issue from 16 Sep 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Sep 15
PATIENTS who legitimately need compounded Ozempic should still have access to the medication, even if a government ban comes into effect, advises the Consumers Health Forum of Australia (CHF).
QUEENSLAND pharmacists can commence their full scope of practice journey with the newly launched Prescribing Hormonal Contraceptives Course by the Australasian College of Pharmacy.
A SURGE in international and local demand has led to complementary medicines becoming a huge success story for Australia, according to peak body Complementary Medicines Australia.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.